-
Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK. J. Urol. (IF 5.9) Pub Date : 2024-09-03 Neal D Shore,Ugo De Giorgi,Stephen J Freedland
-
A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation. J. Urol. (IF 5.9) Pub Date : 2024-09-03 Steven E Canfield,Arvin K George,Joshua S Jue,Sara C Lewis,Matthew S Davenport,Varaha S Tammisetti,Mahir Maruf,Leonardo D Borregalaes,Yara Kadria-Vili,Jon A Schwartz,Jennifer West,Naomi J Halas,Ardeshir R Rastinehad
PURPOSE Focal therapy aims to provide a durable oncologic treatment option for men with prostate cancer (PCa), while preserving their quality of life. Most focal therapy modalities rely on the direct tissue effect, resulting in a possible nontargeted approach to ablation. Here, we report the results of the first human feasibility trial utilizing nanoparticle-directed focal photothermal ablation for
-
Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: 5-year Results From the ROBUST I Study. J. Urol. (IF 5.9) Pub Date : 2024-08-30 Jessica DeLong,Ramón Virasoro,Merycarla Pichardo,Rafael Estrella,Ramón Rodríguez Lay,Gustavo Espino,Sean Elliott
PURPOSE To report the 5-year study close-out results for the ROBUST I trial evaluating the safety and efficacy of the Optilume drug-coated balloon (DCB) for men with short, recurrent bulbar urethral strictures. MATERIALS AND METHODS Adult men with recurrent bulbar urethral strictures ≤ 2 cm long and lumen < 12 Fr were included in the study and treated with the Optilume DCB. Outcome measures included
-
Time to Change Our Mindset! Integrating Sustainability Into Urological Practice. J. Urol. (IF 5.9) Pub Date : 2024-08-27 Golena Fernandez Moncaleano,Nadya York,Khurshid R Ghani
-
Diagnostic Pathway Outcomes for Biparametric Magnetic Resonance Imaging-Targeted Lesions Using Cognitive Registration and Freehand Transperineal Prostate Biopsy in Biopsy-Naïve Men (CRAFT Single-Center Study). J. Urol. (IF 5.9) Pub Date : 2024-08-27 Samara Fleville,Carole O'Neill,Daniel Safar,Alex Macleod,Colin Mulholland,Filip Subin
PURPOSE Enhanced histological detection of clinically significant prostate cancer is the goal of the prebiopsy imaging pathway. Risk stratification at a prebiopsy meeting can facilitate optimization of lesion targeting. We aimed to evaluate the feasibility of cognitive registration, freehand transperineal prostate biopsy in a biopsy-naïve population following biparametric MRI for the detection of clinically
-
Epididymal Cyst Lesions Are Not Associated With Impaired Semen Parameters Among Men Presenting for Fertility Evaluation. J. Urol. (IF 5.9) Pub Date : 2024-08-26 Daniel R Greenberg,Luis C Gago,Sai Kaushik S R Kumar,Evan J Panken,Emily J Ji,Kyle P Tsai,Kian Asanad,Solomon Hayon,Robert E Brannigan,Joshua A Halpern
PURPOSE Epididymal cyst lesions (ECLs) include both spermatoceles and epididymal cysts and are often incidentally found on physical exam or scrotal US (SUS). We aimed to determine the association of ECLs and semen parameters among men presenting for fertility evaluation. MATERIALS AND METHODS We reviewed men at our institution who had at least 1 semen analysis and SUS available for review between 2002
-
Why Did My Paper Take So Long To Review? J. Urol. (IF 5.9) Pub Date : 2024-08-26 George Koch,D Robert Siemens
-
Letter: Complications: The Experience of the Urologic Surgeon. J. Urol. (IF 5.9) Pub Date : 2024-08-22 Kevin B Ginsburg,Mahin Mirza,Khurshid R Ghani,Karla Witzke
-
Impact of SPY Fluorescence Angiography on Incidence of Ureteroenteric Stricture After Urinary Diversion. J. Urol. (IF 5.9) Pub Date : 2024-08-20 Clinton Yeaman,Grace Ignozzi,Aisha Kazeem,Sumit Isharwal,Tracey L Krupski,Stephen H Culp
PURPOSE Ureteroenteric strictures (UESs) are a common and morbid complication of radical cystectomy and urinary diversions. UES occurs in 4% to 25% of all patients undergoing urinary diversion, and anastomotic ischemia is implicated in stricture formation. SPY fluorescence angiography is a technology that can be employed during open surgery that allows for evaluation of ureteral perfusion. MATERIALS
-
Updates to Male Infertility: AUA/ASRM Guideline (2024). J. Urol. (IF 5.9) Pub Date : 2024-08-15 Robert E Brannigan, Linnea Hermanson, Janice Kaczmarek, Sennett K Kim, Erin Kirkby, Cigdem Tanrikut
In 2023 the American Urological Association (AUA) requested an Update Literature Review (ULR) to incorporate new evidence generated since the 2020 publication of this Guideline. The resulting 2024 Guideline Amendment addresses updated recommendations to provide guidance on the appropriate evaluation and management of the male partner in an infertile couple.
-
Randomized Controlled Trial of Ultrasonic Propulsion-Facilitated Clearance of Residual Kidney Stone Fragments vs Observation. J. Urol. (IF 5.9) Pub Date : 2024-08-15 Mathew D Sorensen, Barbrina Dunmire, Jeff Thiel, Bryan W Cunitz, Barbara H Burke, Branda J Levchak, Christina Popchoi, Arturo E Holmes, John C Kucewicz, M Kennedy Hall, Manjiri Dighe, Jessica C Dai, Fionnuala C Cormack, Ziyue Liu, Michael R Bailey, Michael P Porter, Jonathan D Harper
Ultrasonic propulsion is an investigational procedure for awake patients. Our purpose was to evaluate whether ultrasonic propulsion to facilitate residual kidney stone fragment clearance reduced relapse.
-
Generative AI Platform for Automating Social Media Posts From Urology Journal Articles: A Cross-Sectional Study and Randomized Assessment. J. Urol. (IF 5.9) Pub Date : 2024-08-14 Lorenzo Storino Ramacciotti,Francesco Cei,Jacob S Hershenhouse,Daniel Mokhtar,Severin Rodler,Karanvir Gill,David Strauss,Luis G Medina,Jie Cai,Andre Luis Abreu,Mihir M Desai,Rene Sotelo,Inderbir S Gill,Giovanni E Cacciamani
PURPOSE This cross-sectional study assessed a generative-AI platform to automate the creation of accurate, appropriate, and compelling social-media (SoMe) posts from urological journal articles. MATERIALS AND METHODS One hundred SoMe-posts from the top 3 journals in urology X (Twitter) profiles were collected from Aug-2022 to Oct-2023 A freeware GPT-tool was developed to auto-generate SoMe posts, which
-
Incontinence After Prostate Treatment: What Does the Future Hold? J. Urol. (IF 5.9) Pub Date : 2024-08-13 Benjamin N Breyer,Alex J Vanni,O Lenaine Westney
-
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer. J. Urol. (IF 5.9) Pub Date : 2024-08-09 Neal Shore,Christopher Pieczonka,Sean Heron,Mukaram Gazi,David Cahn,Laurence H Belkoff,Aaron Berger,Brian Mazzarella,Joseph Veys,Charles Idom,David Morris,Gautam Jayram,Alexander Engelman,Paul Dato,Richard Bevan-Thomas,David R Wise,Mary Kay Hardwick,Susan Rojahn,Paige Layman,Brandie Heald,Rachel E Ellsworth,Kathryn E Hatchell,Robert L Nussbaum,Sarah M Nielsen,Edward D Esplin
PURPOSE Identification of pathogenic germline variants in patients with prostate cancer can help inform treatment selection, screening for secondary malignancies, and cascade testing. Limited real-world data are available on clinician recommendations following germline genetic testing in patients with prostate cancer. MATERIALS AND METHODS Patient data and clinician recommendations were collected from
-
The Journal of Urology® Home Study Course 2024 Volume 211/212: Erratum. J. Urol. (IF 5.9) Pub Date : 2024-08-08
-
Randomized Trial of Transverse vs Vertical Extraction Site Incision After Robotic Radical Prostatectomy. J. Urol. (IF 5.9) Pub Date : 2024-08-08 Christopher D Gaffney, Emily A Vertosick, Vincent Laudone, Alvin C Goh, Sigrid V Carlsson, Eugene Pietzak, Timothy Donahue, Robert Smith, Karim Touijer, Andrew J Vickers, Behfar Ehdaie
Incisional hernias are a frequent complication following robotic radical prostatectomy. Observational data in men undergoing robotic prostatectomy suggest that transverse closure resulted in lower hernia rates than vertical closure. We sought to compare the incidence of incisional hernia after robotic radical prostatectomy after vertical and transverse extraction site closure.
-
Creation of a Novel Classification System (PTNM) for Peyronie's Disease and Penile Curvature Using Evidence-Based Criteria. J. Urol. (IF 5.9) Pub Date : 2024-08-08 Landon Trost, John Mulhall, Wayne Hellstrom
Our goal was to identify new Peyronie's disease (PD) subtypes, non-PD penile curvature classifications, and define active (acute) vs stable (chronic) phases of disease using evidence-based analyses.
-
Initial Clinical Experience With a Novel Robotically Assisted Platform for Combined Mini-Percutaneous Nephrolithotomy and Flexible Ureteroscopic Lithotripsy. J. Urol. (IF 5.9) Pub Date : 2024-08-08 Jaime Landman, Ralph V Clayman, Andrei D Cumpanas, Roshan M Patel, Pengbo Jiang, Zachary E Tano, Sohrab N Ali, Nancy L Sehgel, Jacob W Caldwell, Chiara Gatti, William J Petraiuolo, Paul T Morris, Mihir M Desai
We sought to evaluate the technical feasibility of performing a combined robotically assisted mini-percutaneous nephrolithotomy (PCNL) and flexible ureteroscopy (URS) procedure by a single urologist using the MONARCH Platform, Urology (Johnson & Johnson MedTech, Redwood City, California).
-
Perineal Urethrostomy for Complex Urethral Strictures: Long-Term Patient-Reported Outcomes from a Reconstructive Referral Center and a Scoping Literature Review. J. Urol. (IF 5.9) Pub Date : 2024-08-02 Jakob Klemm, Roland Dahlem, Robert J Schulz, Daniel R Stelzl, Dejan K Filipas, Christian Brömmer, Shahrokh F Shariat, Margit Fisch, Malte W Vetterlein
There is a paucity of long-term objective and patient-reported outcomes after definitive perineal urethrostomy for complex urethral strictures. Our objective is to determine comprehensive long-term success of perineal urethrostomy with our 15-year experience at a reconstructive referral center.
-
The Evolving Role of Genetic Testing in Monogenic Kidney Stone Disease: Spotlight on Primary Hyperoxaluria. J. Urol. (IF 5.9) Pub Date : 2024-08-02 Matthew C Breeggemann, Peter C Harris, John C Lieske, Gregory E Tasian, Kyle D Wood
Multiple factors are thought to give rise to common, recurrent kidney stone disease, but for monogenic stone disorders a firm diagnosis is possible through genetic testing. The autosomal recessive primary hyperoxalurias (PH) are rare but important forms of monogenic kidney stone disease. All 3 types of PH are caused by inborn errors of glyoxylate metabolism in the liver, leading to hepatic oxalate
-
Exploring the Genetic Risk of Childhood Daytime Urinary Incontinence: A Genome-Wide Association Study. J. Urol. (IF 5.9) Pub Date : 2024-08-02 Anders Breinbjerg, Cecilie Siggaard Jørgensen, G Bragi Walters, Jakob Grove, Thomas D Als, Konstantinos Kamperis, Lilja Stéfansdóttir, Janne P Thirstrup, Britt Borg, Clara Albiñana, Bjarni J Vilhjálmsson, Viðar Ö Eðvarðsson, Hreinn Stefánsson, Preben B Mortensen, Esben Agerbo, Thomas Werge, Anders Børglum, Ditte Demontis, Kári Stefánsson, Søren Rittig, Jane Hvarregaard Christensen
Childhood incontinence is stigmatized and underprioritized, and a basic understanding of its pathogenesis is missing. Our goal was to identify risk-conferring genetic variants in daytime urinary incontinence (DUI).
-
Post-Vasectomy Semen Analysis Compliance With Utilization of a Mail-In Semen Analysis Kit. J. Urol. (IF 5.9) Pub Date : 2024-08-02 Catherine Gu, Andre Belarmino, Stacey A Kenfield, Dan Nolte, Daniel Civello, James F Smith, Stan Honig, Akanksha Mehta, Nahid Punjani, Lori B Lerner
The American Urological Association recommends post-vasectomy semen analysis (PVSA) to verify successful vasectomy. However there remains poor patient compliance. We sought to assess whether mail-in PVSA improves patient compliance across a wide range of practice types.
-
Reduction of Overactive Bladder Medications in Spinal Cord Injury With Self-Administered Neuromodulation; a Randomized Trial. J. Urol. (IF 5.9) Pub Date : 2024-08-02 Argyrios Stampas, Radha Korupolu, Kyung Hyun Lee, Betsy Salazar, Rose Khavari
To evaluate if self-administered bladder neuromodulation with transcutaneous tibial nerve stimulation can safely replace overactive bladder medications in people with spinal cord injury.
-
Apalutamide for High-Risk Localized Prostate Cancer Following Radical Prostatectomy (Apa-RP). J. Urol. (IF 5.9) Pub Date : 2024-08-01 Neal Shore, Jason Hafron, Daniel Saltzstein, Gordon Brown, Laurence Belkoff, Pankaj Aggarwal, Jennifer Phillips, Amitabha Bhaumik, Tracy McGowan
Approximately 25 to 50% of patients with high-risk localized prostate cancer experience biochemical recurrence within 2 years of radical prostatectomy. The Apa-RP study (NCT04523207) investigated whether adjuvant apalutamide plus androgen deprivation therapy in high-risk patients who have undergone radical prostatectomy improved biochemical recurrence-free survival.
-
The Impact of Social Deprivation on Anterior Urethral Stricture Recurrence After Urethroplasty - A Trauma and Urologic Reconstructive Network of Surgeons (TURNS) Analysis. J. Urol. (IF 5.9) Pub Date : 2024-08-01 Hiren V Patel, Kevin D Li, Keith Rourke, Thomas G Smith, Bryan B Voelzke, Jeremy B Myers, Joshua A Broghammer, Nejd F Alsikafi, Jill C Buckley, Lee C Zhao, Sean P Elliott, Alex J Vanni, Andrew C Peterson, Bradley A Erickson, Benjamin N Breyer
Several factors influence recurrence after urethral stricture repair. The impact of socioeconomic factors on stricture recurrence after urethroplasty is poorly understood. This study aims to assess the impact that social deprivation, an area-level measure of disadvantage, has on urethral stricture recurrence after urethroplasty.
-
Moving the Needle in Early Stage Testicular Germ Cell Tumor Management: The MAGESTIC Trial. J. Urol. (IF 5.9) Pub Date : 2024-07-31 Muhannad Alsyouf,Siamak Daneshmand
-
Management and Oncologic Outcomes of Incidental Prostate Cancer After Transurethral Resection of the Prostate in Denmark. J. Urol. (IF 5.9) Pub Date : 2024-07-31 Riccardo Leni, Andrew Julian Vickers, Klaus Brasso, Francesco Montorsi, Alberto Briganti, Torben Kjær Nielsen, Andreas Røder, Hein Vincent Stroomberg
Approximately 1 in 10 patients without prior prostate biopsy undergoing surgery for lower urinary tract symptoms harbor incidental prostate cancer, however, practice guidelines do not provide recommendations for its management. We aimed at describing the oncologic outcomes of patients with grade group (GG) 1 and 2 prostate cancer diagnosed at transurethral resection of the prostate (TURP).
-
Preoperative Oxybutynin Reduces Postoperative Opioid Use Following Common Pediatric Urology Surgeries. J. Urol. (IF 5.9) Pub Date : 2024-07-31 Michael Lin-Brande, Nicholas H Chakiryan, Aaron P Bayne
Urologic surgery involving placement of an indwelling ureteral and/or urethral drain can be associated with significant catheter-related bladder discomfort causing increased postoperative morbidity and opioid medication use. We sought to assess if a single dose of oxybutynin given preoperatively reduces immediate postoperative opioid use in common pediatric urology surgeries.
-
Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis. J. Urol. (IF 5.9) Pub Date : 2024-07-30 Giuseppe Ottone Cirulli, Matthew Davis, Alex Stephens, Giuseppe Chiarelli, Marco Finati, Nicholas Corsi, Eric Williams, Rafe Affas, Akshay Sood, Nicolò Buffi, Giovanni Lughezzani, Giuseppe Carrieri, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Craig Rogers, Firas Abdollah
Randomized studies assessing the effect of PSA screening on mortality in non-Hispanic Black (NHB) men are lacking. We aimed to assess the association between PSA screening and survival among NHB men in comparison to non-Hispanic White (NHW) men in a racially diverse real-world North American population.
-
Early PSA Response by 6 Months is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of TITAN Trial. J. Urol. (IF 5.9) Pub Date : 2024-07-26 Soumyajit Roy, Yilun Sun, Kim N Chi, Michael Ong, Shawn Malone, Christopher J D Wallis, Amar U Kishan, Julia Malone, Umang Swami, Georges Gebrael, Jason R Brown, Angela Y Jia, Scott C Morgan, Fred Saad, Simon Chowdhury, Neeraj Agarwal, Daniel E Spratt
Early PSA response has been found to be prognostic of outcome in metastatic hormone sensitive prostate cancer (mHSPC). We performed a secondary analysis of TITAN trial to determine if early PSA response was predictive of treatment efficacy in mHSPC patients.
-
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer. J. Urol. (IF 5.9) Pub Date : 2024-07-25 Daniel Halstuch, Ronald Kool, Gautier Marcq, Rodney H Breau, Peter C Black, Bobby Shayegan, Michael Kim, Ionut Busca, Hamidreza Abdi, Mark T Dawidek, Michael Uy, Gagan Fervaha, Fabio L Cury, Nimira S Alimohamed, Claudio Jeldres, Ricardo Rendon, Fadi Brimo, D Robert Siemens, Girish S Kulkarni, Wassim Kassouf, Jonathan I Izawa
Outcomes of radiation-based therapy (RT) for muscle-invasive bladder cancer (MIBC) with histologic subtypes of urothelial cancer (HS-UC) are lacking. Our objective was to compare survival outcomes of pure urothelial carcinoma (PUC) to HS-UC after RT.
-
miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. J. Urol. (IF 5.9) Pub Date : 2024-07-25 Anna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, Per-Olof Lundgren, Viktor Skokic, Bjarte Almås, Hege Sagstuen Haugnes, Torgrim Tandstad, Olof Akre, Gabriella Cohn-Cedermark, Olav Dahl, Anders Kjellman
The SWENOTECA-MIR prospective multicenter study aims to assess the clinical value of miR-371a-3p as a novel marker in metastatic germ cell tumor patients undergoing retroperitoneal lymph node dissection (RPLND), to predict the presence of viable residual tumor.
-
Urology HEIRS: A Feasibility and Acceptability Study for Video-Based Research on Physician-Family Communication in Pediatric Urology Visits. J. Urol. (IF 5.9) Pub Date : 2024-07-10 Francesca A Williamson, Jessica Nina Lester, Jennifer K Mattei, Rosalia Misseri, Jeremy Koehlinger, Kirstan Meldrum, Martin Kaefer, Richard Rink, Joshua Roth, Konrad M Szymanski, Benjamin Whittam, Pankaj P Dangle
Patient- and family-centered communication is essential to healthcare equity. However, less is known about how urologists implement evidence-based communication and dynamics involved in caring for diverse pediatric patients and caregivers. We sought to evaluate the feasibility and acceptability using video-based research to characterize physician-family communication in pediatric urology.
-
MP46-08 Predicting the Risk of Failed Trial Without Catheter Following Rezum Therapy: Erratum. J. Urol. (IF 5.9) Pub Date : 2024-07-09
-
Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial. J. Urol. (IF 5.9) Pub Date : 2024-07-09 Satoru Takahashi, Kumiko Kato, Osamu Yokoyama, Mineo Takei, Momokazu Gotoh
We aimed to evaluate the therapeutic efficacy and safety of TAS-303, a highly selective noradrenaline reuptake inhibitor, in Japanese women with stress urinary incontinence (SUI).
-
Prostate-Specific Antigen Stratification for Predicting Advanced Prostate Cancer Events in Men Approaching Age Limits for Recommended Screening. J. Urol. (IF 5.9) Pub Date : 2024-07-05 Paul Riviere,Leah N Deshler,Kylie M Morgan,Edmund M Qiao,Alex K Bryant,Brent S Rose
PURPOSE Our goal was to quantify the ability of various PSA values in predicting the likelihood of developing metastatic or fatal prostate cancer in older men. MATERIALS AND METHODS We used a random sample of patients in the US Veterans Health Administration to identify 80,706 men who had received PSA testing between ages 70 to 75. Our primary end point was time to development of either metastatic
-
Mixed Gonadal Dysgenesis: A Narrative Literature Review and Clinical Primer for the Urologist. J. Urol. (IF 5.9) Pub Date : 2024-07-05 Lauren E Corona,Victoria Lee,Allison Goetsch Weisman,Ilina Rosoklija,Josephine Hirsch,Jax Whitehead,Abdullah Almaghraby,Jaclyn Papadakis,Briahna Yuodsnukis,Diane Chen,Courtney Finlayson,Elizabeth Yerkes,Earl Y Cheng,Emilie K Johnson
PURPOSE Mixed gonadal dysgenesis is a difference of sex development that is often confused with other conditions. Individuals have a 45,X/46,XY karyotype. Gonads are characterized by a streak gonad and a dysgenetic testis at varying levels of descent. Persistent Müllerian structures are typical (eg, hemi-uterus). There is significant phenotypic heterogeneity of the internal and external genitalia that
-
Development of a Novel Prediction Tool for Response to First-Line Treatments of Monosymptomatic Nocturnal Enuresis-A Randomized, Controlled International Multicenter Study (DRYCHILD). J. Urol. (IF 5.9) Pub Date : 2024-07-01 Cecilie Siggaard Jørgensen, Lien Dossche, Rongqun Zhai, Michal Maternik, Konstantinos Kamperis, Anders S Breinbjerg, Sevasti Karamaria, Kristina Thorsteinsson, Britt Borg, Yihe Wang, Shuai Li, Ann Raes, Lu Wei, Aleksandra Żurowska, Søren Hagstrøm, Johan Vande Walle, Wen Jian Guo, Søren Rittig
Nocturnal urine volume and bladder reservoir function are key pathogenic factors behind monosymptomatic nocturnal enuresis (MNE). We investigated the predictive value of these together with other demographic and clinical variables for response to first-line treatments in children with MNE.
-
Adults With Spina Bifida Fare Worse than Young Adults: A Systemic Vulnerability in Urinary Tract Infection-Related Hospital Care. J. Urol. (IF 5.9) Pub Date : 2024-07-01 Kathy H Huen, Carol A Davis-Dao, Lois Sayrs, Louis Ehwerhemuepha, Chloe Martin-King, Zeev Kain
We aim to estimate the odds of urinary tract infection (UTI)-related hospital care in spina bifida (SB) patients age 18 to 25 years as compared with patients with SB in adolescence (11-17 years) or adulthood (26-35 years). We hypothesize that patients with SB in the typical transitional age, 18 to 25 years, will have higher odds of UTI-related hospital care as compared to adolescent SB patients or
-
Updates to Incontinence After Prostate Treatment: AUA/GURS/SUFU Guideline (2024). J. Urol. (IF 5.9) Pub Date : 2024-06-27 Benjamin N Breyer,Sennett K Kim,Erin Kirkby,Alexis Marianes,Alex J Vanni,O Lenaine Westney
PURPOSE In 2023 the American Urological Association (AUA) requested an Update Literature Review (ULR) to incorporate new evidence generated since the 2019 publication of this Guideline. The resulting 2024 Guideline Amendment addresses updated recommendations to provide guidance for the care of patients with incontinence after prostate treatment (IPT). MATERIALS AND METHODS In 2023, the IPT Guideline
-
Development of the UroARC Surgical Calculator: A Novel Risk Calculator for Older Adults Undergoing Surgery for Bladder Outlet Obstruction. J. Urol. (IF 5.9) Pub Date : 2024-06-26 Farnoosh Nik-Ahd, Shoujun Zhao, W John Boscardin, Lufan Wang, Kenneth Covinsky, Anne M Suskind
Bladder outlet obstruction (BOO) is common in older adults. Many older adults who pursue surgery have additional vulnerabilities affecting surgical risk, including frailty. A clinical tool that builds on frailty to predict surgical outcomes for the spectrum of BOO procedures would be helpful to aid in surgical decision-making but does not currently exist.
-
Association of Baseline MRI PI-RADS Score With Prostate Cancer Active Surveillance Early Biopsy Reclassification: Data From the Michigan Urological Surgery Improvement Collaborative (MUSIC). J. Urol. (IF 5.9) Pub Date : 2024-06-25 Kiran R Nandalur, Chen Shen, Lil Zhao, Sayf Al-Katib, Joseph Lee, Brian Seifman, Hong Ye, Kevin Ginsburg, Thomas Quinn, Sirisha Nandalur, Arvin George, David Gangwish, Abhay Dhaliwal, Connor Erwin, Amanda Young, Akram Albeer, Jason Hafron
The purpose of our study was to evaluate the association of baseline MRI PI-RADS score with biopsy reclassification in a multicenter active surveillance cohort.
-
Establishment of a Comprehensive Urology Program for Gay and Bisexual Men. J. Urol. (IF 5.9) Pub Date : 2024-06-17 Rahul Prabhu,Eric V Li,Channa Amarasekera
-
Radical Prostatectomy Without Prior Biopsy in Selected Patients Evaluated by 18F-Labeled Prostate-Specific Membrane Antigen-Ligand Positron Emission Tomography/Computed Tomography and Multiparameter Magnetic Resonance Imaging: A Single-Center, Prospective, Single-Arm Trial. J. Urol. (IF 5.9) Pub Date : 2024-06-17 Shaoxi Niu, Xiaohui Ding, Baichuan Liu, Liyan Ao, Haiyi Wang, Wei Chen, Baixuan Xu, Alberto Olivero, Jiajin Liu, Jiangping Gao, Yu Gao, Weijun Fu, Xin Ma, Hongzhao Li, Baojun Wang, Yachao Liu, Xu Zhang
This study aimed to verify the feasibility and short-term prognosis of prostatectomy without biopsy.
-
Pediatric Urologists' Views on the US News and World Report. J. Urol. (IF 5.9) Pub Date : 2024-06-17 N Valeska Halstead, Ilina Rosoklija, David I Chu, Emilie K Johnson, Earl Y Cheng
To understand the general attitudes of pediatric urologists regarding the United States News and World Report rankings for Best Children's Hospitals in Urology.
-
The Genomics and Natural History of MRI-Visible vs MRI-Invisible Prostate Cancers: Clinical Implications. J. Urol. (IF 5.9) Pub Date : 2024-06-12 Laurence Klotz
-
Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal Masses. J. Urol. (IF 5.9) Pub Date : 2024-06-12 Maria B Antony, Zach Kozel, Nikhil Gopal, Lauren Loebach, Adam R Metwalli, Sandeep Gurram, W Marston Linehan, Mark W Ball
Reoperative partial nephrectomy (RePN) offers several advantages for the treatment of recurrent, multifocal renal masses. RePN has been previously demonstrated to be technical feasibility and delay the need for renal replacement therapy. However, there is still inherent complexity and known risks to reoperative nephrectomy. We studied the largest population of reoperative partial nephrectomies to characterize
-
Estimating the Effect of Radical Prostatectomy: Combining Data From the SPCG4 and PIVOT Randomized Trials With Contemporary Cohorts. J. Urol. (IF 5.9) Pub Date : 2024-06-12 Andrew Vickers, Emily Vertosick, Lisa Langsetmo, Philipp Dahm, Gunnar Steineck, Timothy J Wilt
Two randomized trials (SPCG4 and PIVOT) have compared surgery to conservative management for localized prostate cancer. The applicability of these trials to contemporary practice remains uncertain. We aimed to develop an individualized prediction model for prostate cancer mortality comparing immediate surgery at a high-volume center to active surveillance.
-
Artificial Intelligence Improves the Ability of Physicians to Identify Prostate Cancer Extent. J. Urol. (IF 5.9) Pub Date : 2024-06-11 Sakina Mohammed Mota, Alan Priester, Joshua Shubert, Jeremy Bong, James Sayre, Brittany Berry-Pusey, Wayne G Brisbane, Shyam Natarajan
Defining prostate cancer contours is a complex task, undermining the efficacy of interventions such as focal therapy. A multireader multicase study compared physicians' performance using artificial intelligence (AI) vs standard-of-care methods for tumor delineation.
-
Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multi-Site Single-Institution Prospective Study. J. Urol. (IF 5.9) Pub Date : 2024-06-11 Mouneeb M Choudry, Adri M Durant, Victoria S Edmonds, Christopher J Warren, Katie L Kunze, Michael A Golafshar, Sarah M Nielsen, Edward D Esplin, Jack R Andrews, N Jewel Samadder, Mark D Tyson
This study aimed to investigate the prevalence of pathogenic germline variants (PGV) in hereditary cancer genes utilizing a universal testing approach and to determine the rate of PGV that would have been missed based on National Comprehensive Cancer Network (NCCN) guidelines in genitourinary (GU) malignancies.
-
The Future of Urology: From Carbon Footprint to Artificial Intelligence. J. Urol. (IF 5.9) Pub Date : 2024-06-07 Thomas Knoll,Arnulf Stenzl
-
What Is the Future of Cystoscopy for Detecting Urothelial Carcinoma? J. Urol. (IF 5.9) Pub Date : 2024-06-07 Christopher B Anderson
-
Evidence-Based Guidelines in Urology: A Way Forward Together. J. Urol. (IF 5.9) Pub Date : 2024-06-07 Philipp Dahm,Daniel A Gonzalez-Padilla,Holger J Schünemann
-
The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Guérin in Treating Nonmuscle-Invasive Bladder Cancer. J. Urol. (IF 5.9) Pub Date : 2024-06-07 Marilyn L Kwan, Zinian Wang, Reina Haque, Valerie S Lee, Janise M Roh, Isaac J Ergas, Kimberly L Cannavale, Rachel Pratt, Maciej Goniewicz, Ronald K Loo, David S Aaronson, Charles P Quesenberry, Yuesheng Zhang, Christine B Ambrosone, Lawrence H Kushi, Li Tang
Nonmuscle-invasive bladder cancer (NMIBC) has high recurrence rates and is often treated with mitomycin C (MMC) and bacillus Calmette-Guérin (BCG). Their efficacy relies on phase 2 enzyme metabolism and immune response activation, respectively. Dietary isothiocyanates, phytochemicals in cruciferous vegetables, are phase 2 enzyme inducers and immunomodulators, and may impact treatment outcomes. We investigated
-
Letter: Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths for Treatment of Nephrolithiasis. J. Urol. (IF 5.9) Pub Date : 2024-05-30 Lucas B Vergamini,Bristol B Whiles,Wilson R Molina
-
Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J. Urol. (IF 5.9) Pub Date : 2024-05-30 Andrew Zganjar, Abhinav Khanna, Dan Joyce, Paige Nichols, Cameron Britton, Christine M Lohse, John C Cheville, Sounak Gupta, Aaron M Potretzke, R Houston Thompson, Bradley C Leibovich, Stephen A Boorjian, Vidit Sharma
The AUA guidelines introduced a new risk group stratification system based primarily on tumor stage and grade to guide surveillance for patients treated surgically for localized renal cell carcinoma (RCC). We sought to evaluate the predictive ability of these risk groups using progression-free survival (PFS) and cancer-specific survival (CSS), and to compare their performance to that of our published
-
Bladder Exstrophy Consortium After 8 Years: The Short- and Intermediate-Term Outcomes. J. Urol. (IF 5.9) Pub Date : 2024-05-24 Chad B Crigger,John P Gearhart
-
Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial. J. Urol. (IF 5.9) Pub Date : 2024-05-24 Clinton D Bahler, Isamu Tachibana, Mark Tann, Katrina Collins, Jordan K Swensson, Mark A Green, Carla J Mathias, Yan Tong, Courtney Yong, Ronald S Boris, Eric Brocken, Gary D Hutchins, Justin B Sims, Danielle V Hill, Nathaniel Smith, Christopher Ferari, Harrison Love, Michael O Koch
Survivors of surgically managed prostate cancer may experience urinary incontinence and erectile dysfunction. Our aim was to determine if 68Ga-prostate-specific membrane antigen-11 positron emission tomography CT (PSMA-PET) in addition to multiparametric (mp) MRI scans improved surgical decision-making for nonnerve-sparing or nerve-sparing approach.
-
Prevalence of Cognitive and Manual Dexterity Disorders Among Men Following Artificial Urinary Sphincter Placement. J. Urol. (IF 5.9) Pub Date : 2024-05-24 Jacqueline Zillioux, Fabian Camacho, Roger Anderson, Wen You, David E Rapp
Cognitive ability and manual dexterity sufficient to operate an artificial urinary sphincter (AUS) are critical for device function and safety. We aimed to define the incidence of cognitive and/or dexterity disorders among men after AUS. We secondarily aimed to assess for association between these disorders and post-implant complications.
-
Location-Based Oncological Outcomes of Sentinel Node Dissection in Radical Prostatectomy. J. Urol. (IF 5.9) Pub Date : 2024-05-24 Matteo Droghetti, Oktay Ozman, Anne-Claire Berrens, Pietro Piazza, Alexandro Paccapelo, Roos van Vliet, Riccardo Schiavina, Eugenio Brunocilla, Elise Bekers, Maarten Donswijk, Fijs W B van Leeuwen, Henk van der Poel
To assess the oncological outcomes of sentinel-node dissection during radical prostatectomy according to nodal location in comparison to extended pelvic lymph node dissection.